Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
- 1 January 1998
- journal article
- clinical trial
- Published by Taylor & Francis in The European Journal of Contraception & Reproductive Health Care
- Vol. 3 (3) , 113-120
- https://doi.org/10.3109/13625189809051413
Abstract
To assess the contraceptive efficacy, cycle control and acceptability of two monophasic oral contraceptives containing either 30 micrograms ethinylestradiol plus 150 micrograms desogestrel or 30 micrograms ethinylestradiol plus 75 micrograms gestodene.Keywords
This publication has 9 references indexed in Scilit:
- Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgarisContraception, 1996
- Contraceptive efficacy and safety of a monophasic oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl estradiol: United States clinical experience using a “Sunday start” approach**Supported by organon Inc., West Orange, New Jersey.Fertility and Sterility, 1995
- GestodeneDrugs, 1995
- Classification and comparison of oral contraceptives containing new generation progestogensHuman Reproduction Update, 1995
- Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai womenContraception, 1995
- Clinical comparison of monophasic oral contraceptive preparations of gestodene/ ethinyl estradiol and desogestrel/ethinyl estradiolContraception, 1994
- Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and DesogestrelActa Obstetricia et Gynecologica Scandinavica, 1988
- Side effects and discontinuation of oral contraceptive use in southern BrazilJournal of Biosocial Science, 1986
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985